Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of ALX1-11 (Preos) in Postmenopausal Osteoporosis
NCT00172107Phase 2Completed
- Sponsor
- Takeda
- Start
- May 1995
- Primary completion
- Mar 1997
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of parathyroid hormone 1-84 in postmenopausal osteoporosis, sponsored by Takeda. Started May 1995; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00172107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172107.